| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |